Free Webex Call
The Blood Transfusion Devices Market was valued at USD 4.80 Billion in 2024, and is expected to reach USD 6.61 Billion by 2030, rising at a CAGR of 5.68%. Blood transfusion devices, which include blood bags, transfusion filters, infusion pumps, and apheresis systems, are vital for ensuring the safe and efficient collection, processing, and administration of blood components. The increasing prevalence of medical conditions such as anemia, cancer, hemophilia, and kidney disease - which often necessitate recurrent transfusions - is a key factor propelling market growth. Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Additionally, the rise in emergency cases, including trauma and obstetric complications, particularly in developing nations with expanding healthcare systems, continues to drive demand. While financial and logistical challenges remain, the market outlook is positive due to technological advancements, increased healthcare spending, and heightened focus on safety and efficiency in transfusion practices. As both developed and emerging markets enhance their healthcare infrastructure, the integration of advanced transfusion technologies is set to accelerate.
Key Market Drivers
Growth in Healthcare Industry
The expanding global healthcare industry is a key driver supporting the growth of the blood transfusion devices market. Generating over USD 4 trillion annually, the healthcare sector includes pharmaceuticals, biotechnology, medical technology, and diagnostics - each playing a pivotal role in supporting transfusion needs.Rising rates of surgical procedures, organ transplants, cancer treatments, and emergency interventions require reliable access to blood components like red cells, platelets, and plasma. However, disparities remain - only 6% of the 313 million global procedures occur in the poorest regions, despite these areas housing over a third of the global population. This imbalance results in higher fatality rates for treatable conditions. With more hospitals and clinics being established, especially in underserved regions, demand for transfusion equipment continues to rise, driven by both clinical need and improvements in infrastructure.
Key Market Challenges
High Capital and Operational Costs
The significant costs associated with blood transfusion equipment remain a major challenge for market expansion. Advanced technologies have improved the quality and safety of transfusion procedures but have also raised the financial barriers for adoption.Establishing modern transfusion facilities requires substantial investment in equipment such as apheresis machines, automated processing systems, and temperature-controlled storage units. In low- and middle-income countries, these upfront and ongoing operational costs often hinder adoption, limiting the reach of quality transfusion care. Budget constraints among healthcare providers further exacerbate disparities in access, affecting both availability and patient outcomes.
Key Market Trends
Expansion of Decentralized Blood Collection Models
An important trend shaping the blood transfusion devices market is the transition toward decentralized collection models. To improve the resilience and reach of blood supply systems, healthcare systems are increasingly deploying mobile collection units, community-based sites, and rural health posts in addition to central facilities.Innovations such as Touch Activated Phlebotomy (TAP) devices are enhancing the convenience and safety of decentralized blood collection by enabling painless, reliable, and self-administered capillary blood draws - without the need for trained phlebotomists. These models offer scalable, flexible solutions for broader population coverage, especially in hard-to-reach areas.
Key Market Players
- Immucor Inc.
- Becton Dickinson and Company
- B. Braun Melsungen AG
- Terumo Corporation
- Grifols SA
- Kaneka Corporation
- Fresenius Kabi AG
- Haemonetics Corporation
- Macopharma SA
- Ecomed Solutions, LLC.
Report Scope
In this report, the Global Blood Transfusion Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:Blood Transfusion Devices Market, By Product:
- Apheresis Systems
- Infusion Devices
- Blood Warmers
- Venous Access Devices
- Filters
- Others
Blood Transfusion Devices Market, By End Use:
- Hospital
- Ambulatory Surgical Centers
- Dialysis Centers
- Blood Bank
- Others
Blood Transfusion Devices Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Blood Transfusion Devices Market.Available Customizations
With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.Company Information
- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
1. Product Overview
2. Research Methodology
3. Executive Summary
5. Global Blood Transfusion Devices Market Outlook
6. North America Blood Transfusion Devices Market Outlook
7. Europe Blood Transfusion Devices Market Outlook
8. Asia Pacific Blood Transfusion Devices Market Outlook
9. South America Blood Transfusion Devices Market Outlook
10. Middle East and Africa Blood Transfusion Devices Market Outlook
11. Market Dynamics
12. Market Trends & Developments
15. Porters Five Forces Analysis
16. Competitive Landscape
Companies Mentioned
- Immucor Inc.
- Becton Dickinson and Company
- B. Braun Melsungen AG
- Terumo Corporation
- Grifols SA
- Kaneka Corporation
- Fresenius Kabi AG
- Haemonetics Corporation
- Macopharma SA
- Ecomed Solutions, LLC.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 185 |
Published | June 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 4.8 Billion |
Forecasted Market Value ( USD | $ 6.61 Billion |
Compound Annual Growth Rate | 5.6% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |